ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs MXN
16.88256
-0.02%
Brent Oil
83.38
-0.11%
Bitcoin
63,878.10
1.13%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. VYNE Therapeutics Inc (VYNE)

  7. VYNE Therapeutics Inc (VYNE) Noticias

VYNE VYNE Therapeutics Inc

2.71
0.09 (3.44%)
06 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
VYNE Therapeutics Inc VYNE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.09 3.44% 2.71 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.64 2.5801 2.7499 2.71 2.62
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/3/202416:16EDGAR2Form S-3 - Registration statement under Securities Act of..
01/3/202416:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202407:12EDGAR2Form 8-K - Current report
02/2/202408:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/1/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202416:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202407:15EDGAR2Form 8-K - Current report
15/12/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/12/202315:00EDGAR2Form 8-K - Current report
04/12/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202315:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/11/202315:30EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202315:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/11/202314:59EDGAR2Form DEF 14A - Other definitive proxy statements
13/11/202306:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202306:46EDGAR2Form 8-K - Current report
02/11/202315:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30/10/202306:30EDGAR2Form 8-K - Current report
04/10/202315:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202315:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202315:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202307:00EDGAR2Form 8-K - Current report
05/7/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
VYNE
VYNE Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados